Search results
Izokibep shows promise in psoriatic arthritis trial By Investing.com
Investing.com· 3 days agoACELYRIN, INC. (NASDAQ: SLRN), a biopharmaceutical company specializing in immunology, announced...
AbbVie’s RINVOQ now indicated for paediatric arthritis in US
Pharmaceutical Technology via Yahoo Finance· 3 days agoAbbVie has announced that its RINVOQ (upadacitinib) is now indicated for treating polyarticular...
FDA Extends Upadacitinib Indications to Kids With Arthritis
Medscape· 4 days agoThe JAK inhibitor's safety profile for patients as young as 2 years was similar to known to the...
Rhode Islanders face massive barriers to health care | Opinion
The Providence Journal via Yahoo News· 2 days agoPaul Adam, of Woonsocket, is the Rhode Island Lead Volunteer for the American Cancer Society Action Network. Psoriatic arthritis controlled my life, taking ...
Pharma Stock Roundup: LLY's CFO Departs, ABBV, AZN Drugs Get CHMP Approval
Zacks via Yahoo Finance· 1 day agoSkyrizi is already approved in the United States and the EU for treating plaque psoriasis, psoriatic...
Inebilizumab 'MITIGATES' Flare Risk in IgG4-Related Disease
Medscape· 1 day agoInebilizumab-cdon reduced the risk for flares by 87% in patients with IgG4-RD, the MITIGATE study showed.
Simponi and Simponi Aria cost: Reducing long-term costs and more
Medical News Today· 5 days agoSimponi and Simponi Aria both contain the active ingredient golimumab. A biosimilar medication is a...
How Can Cardiovascular Risk Be Reduced in Kidney Dialysis?
Medscape· 3 days agoNew data on clazakizumab, a monoclonal antibody targeting interleukin-6 (IL-6), and home...
Star Singer's Illness; AI Imitating the Dead; Internet-Addicted Brains
MedPage Today· 3 days agoHalsey said she has been battling an undisclosed illness and is "lucky to be alive"; the singer said...
VENTYX ALERT: Bragar Eagel & Squire, P.C. is Investigating Ventyx Biosciences, Inc. on Behalf of...
Morningstar· 5 days agoBragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Ventyx Biosciences, Inc. (NASDAQ: VTYX) on behalf of long-term stockholders ...